MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo
Authors
Keywords
Prostate cancer, microRNA, miR-378, MAPK1
Journal
TUMOR BIOLOGY
Volume 37, Issue 2, Pages 2095-2103
Publisher
Springer Nature
Online
2015-09-08
DOI
10.1007/s13277-015-3996-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-378a-3p enhances adipogenesis by targeting mitogen-activated protein kinase 1
- (2015) Nunu Huang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells
- (2015) Wei Zhang et al. Cancer Cell International
- A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer
- (2015) S. Stegeman et al. ENDOCRINE-RELATED CANCER
- Functional significance of aberrantly expressed microRNAs in prostate cancer
- (2015) Yusuke Goto et al. INTERNATIONAL JOURNAL OF UROLOGY
- The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer
- (2015) D. Sun et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer
- (2015) Gui-Ming Zhang et al. PLoS One
- Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing
- (2015) Chunjiao Song et al. PROSTATE
- Loss of miR-378 in prostate cancer, a common regulator of KLK2 and KLK4, correlates with aggressive disease phenotype and predicts the short-term relapse of the patients
- (2014) Margaritis Avgeris et al. BIOLOGICAL CHEMISTRY
- MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer
- (2014) Guang-jun Zhang et al. BMC CANCER
- miR-125bcan enhance skin tumor initiation and promote malignant progression by repressing differentiation and prolonging cell survival
- (2014) Liang Zhang et al. GENES & DEVELOPMENT
- MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer
- (2014) Yongbao Wei et al. Scientific Reports
- The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients
- (2013) M Avgeris et al. BRITISH JOURNAL OF CANCER
- MiR-378 Controls Cardiac Hypertrophy by Combined Repression of Mitogen-Activated Protein Kinase Pathway Factors
- (2013) Jayavarshni Ganesan et al. CIRCULATION
- Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer
- (2013) S Mishra et al. ONCOGENE
- MiR-378 Inhibits Progression of Human Gastric Cancer MGC-803 Cells by Targeting MAPK1 In Vitro
- (2013) Bojian Fei et al. ONCOLOGY RESEARCH
- Report of incidence and mortality in China Cancer Registries, 2008
- (2012) Wan-qing Chen et al. Chinese Journal of Cancer Research
- Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer
- (2012) Han Christine Ngoc Nguyen et al. PROSTATE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now